Brief: Cosmo Pharmaceuticals: Worldwide Distribution Agreement Of AI Device In Colonoscopy With Medtronic
10/04/2019 06:16
April 10 (Reuters) - COSMO PHARMACEUTICALS NV COPN.S :
* COSMO PHARMACEUTICALS ANNOUNCES REVOLUTIONARY ARTIFICIAL
INTELLIGENCE DEVICE IN COLONOSCOPY TO DETECT LESIONS AND
WORLDWIDE DISTRIBUTION AGREEMENT WITH MEDTRONIC
Source text for Eikon: ID:nTENfgitka
Further company coverage: COPN.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Cosmo NV
See all newsFocus: Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation
Ireland's Cosmo recurring revenue rises on winlevi growth, reaffirms FY guidance
Brief: Cosmo Pharmaceuticals H1 EPS EUR -0.279
Cosmo Pharma's male hair loss treatment shows sustained hair growth in year‑long study
Europe Research Roundup: Airbus ,Bechtle, Salzgitter